Journal Home
Search for

Volume 48, Issue 2, Pages 182-185 (March 2009)


View previous. 13 of 30 View next.

Hip fractures in the elderly in Israel—Possible impact of preventable conditions

Elena Segala, Valentina Raichlinb, Sophia Rimbrotc, Chaim Zinmanb, Batia Razd, Sophia Ish-ShalomeCorresponding Author Informationemail address

Received 26 June 2007; received in revised form 2 January 2008; accepted 5 January 2008. published online 22 February 2008.

Abstract 

In the present study we evaluated the possible contribution of different factors to the occurrence of hip fractures in Israel. We assessed medical history, physical activity, body mass index, smoking status, bone turnover markers and calcium regulating hormones levels of 142 consecutive elderly hip fracture patients (HFP), and compared them to 96 community dwelling elderly people without a history of hip fracture. Age and female gender were the strongest predictors of hip fracture, p<0.001 and 0.013. Stepwise logistic regression demonstrated that HFP had higher PTH and lower 25(OH)D3 levels, p=0.002, p<0.001; they were less physically active, p<0.001, and had higher rate of vitamin D insufficiency during winter–spring, compared to summer–autumn, p=0.033. Diabetics had higher risk for hip fracture, p=0.06, OR=3.9 (95% CI 1.50–10.4). Deoxypyridinoline (DPD) cross links levels were 19.35±10.58mg/mg creatinine in HFP and 9.12±3.52 in controls, p<0.0001. Bone alkaline phosphatase (BAP)/DPD ratio was 1.5 in controls compared to 0.53 in HFP. We conclude that age and female gender were the strongest predictors for hip fracture. Diabetic patients had threefold risk for hip fracture. Bone formation/bone resorption ratio was lower in HFP. Vitamin D deficiency and physical inactivity are important preventable risk factors for hip fracture.

a Metabolic Bone Diseases Unit, Rambam Medical Center, P.O.B. 9602, Haifa 31096, Israel

b Department of the Orthopedic Surgery, Rambam Medical Center, P.O.B. 9602, Haifa 31096, Israel

c Department of Internal Medicine A, Ha’ Emek Medical Center, Afula 18101, Israel

d Endocrine Laboratory, Rambam Medical Center, P.O.B. 9602, Haifa 31096, Israel

e The Bruce Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa 31096, Israel

Corresponding Author InformationCorresponding author. Tel.: +972 4 854 2584; fax: +972 4 854 3416.

PII: S0167-4943(08)00005-8

doi:10.1016/j.archger.2008.01.003


View previous. 13 of 30 View next.